Melbourne researchers have shown a type of leukaemia can be successfully ‘reversed’ by coaxing the cancer cells back into normal development.
The discovery was made using a model of B-progenitor acute lymphoblastic leukaemia (B-ALL), the most common cancer affecting children.
Researchers from the Walter and Eliza Hall Institute showed that switching off a gene called Pax5 could cause cancer in a model of B-ALL, while restoring its function could ‘cure’ the disease.
Institute researchers Dr Ross Dickins and Ms Grace Liu led the study with institute colleagues and collaborators in Vienna. The study was published today in the journal Genes & Development.
Ms Liu said the team used a newly developed ‘genetic switch’ technology to inhibit then reactivatePax5 in the leukaemia model.
“Along with other genetic changes, deactivating Pax5 drives normal blood cells to turn into leukaemia cells, which has been shown before,” Ms Liu said. “However we showed for the first time that reactivating Pax5 enabled the cells to resume their normal development and lose their cancer-like qualities, effectively curing the leukaemia. What was intriguing for us was that simply restoring Pax5 was enough to normalise these cancer cells, despite the other genetic changes.”
Read more . . .
The Latest on: Gene switch reverses cancer
[google_news title=”” keyword=”Gene switch reverses cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Gene switch reverses cancer
- Lung Cancer Cells Switch Oncogenic Driverson April 23, 2024 at 6:25 am
Mouse models mimicking the transition from a common form of lung cancer to a more aggressive one may help scientists develop future strategies to prevent this transformation.
- Gene Therapy Newson April 20, 2024 at 5:00 pm
Genetic Signature May Predict Response to Immunotherapy for Non-Small Cell Lung Cancer Feb. 23, 2024 — A new study identified a set of 140 genes that may help predict enhanced disease-free ...
- Gene therapy is halting cancer. Can it work against brain tumors?on April 19, 2024 at 11:58 am
Tumors must have a mutation found in approximately 20% of glioblastomas, and that can be identified by the UCSF500 cancer gene panel test. The second study will be open to glioblastoma patients ...
- Gene Network Interactions Shed Insight into Breast Cancer Onset and Developmenton April 18, 2024 at 2:29 pm
In a new study, published in GEN Biotechnology titled, “Changes in Gene Network Interactions in Breast Cancer Onset and Development,” researchers from Georgia Institute of Technology have ...
- How Melanomas “Break” Genes To Resist Drugson April 12, 2024 at 5:00 pm
Melanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to alleviate the health burden of the disease. Important advances in ...
- Scientists 'switch off' breast canceron April 5, 2024 at 5:00 pm
Scientists have managed to 'switch off' breast cancer for the first time. They found removing a single gene from mice halted tumour growth and even reversed it in some cases. Their study could ...
- Drugs breakthrough could help those with faulty gene avoid breast cancer surgeryon March 28, 2024 at 3:00 am
Giving drugs usually administered in the late stages of breast cancer to healthy people with faulty genes could prevent them from developing the disease, a study has suggested. The discovery could ...
- Turning Back the Clock on Cancer Cells Could Offer New Treatmentson March 27, 2024 at 5:01 pm
“The mutation of SMARCB1 shuts off gene programs that prevent cancer. By targeting DCAF5, we’re turning those gene programs back on,” Radko-Juettner said. “We’re reversing the cancer state because the ...
- Researchers turn back the clock on cancer cells to offer new treatment paradigmon March 27, 2024 at 1:20 pm
First author Sandi Radko-Juettner, PhD, a former St. Jude Graduate School of Biomedical Sciences student, now a Research Program Manager for the Hematological Malignancies Program and senior ...
- Researchers turn back the clock on cancer cells to offer new treatment paradigmon March 26, 2024 at 5:00 pm
Future therapeutic opportunities to reverse cancer "From a therapeutic perspective, our results are fascinating," Radko-Juettner said. "DCAF5 is part of a larger family of DCAF proteins that have ...
via Bing News